Tag: AbbVie
AbbVie Inc.: Goldman Sachs still neutral on the file
Marketzone with MT Newswires 2022 All the news on ABBVIE INC. Analyst Recommendations on ABBVIE INC. 2022 turnover 59,167M…
Posters against psoriasis: Abbvie pauses campaign
Public advertising for prescription drugs is prohibited in Switzerland. Nevertheless, the pharmaceutical company Abbvie has referred to biotech products on posters. The campaign is now suspended. They want to clarify…
Pfizer, Abbvie and Merck & Co steal the show from Roche and Novartis
American drug manufacturers think big. Blockbusters such as those offered by Pfizer, Abbvie and Merck & Co. are missing from the Swiss heavyweights Roche and Novartis. With Keytruda, the US…
AbbVie: 13% increase in adjusted EPS in the 4th quarter
(CercleFinance.com) – AbbVie announces that it achieved adjusted EPS of $3.31 for the fourth quarter of 2021, up 13.3%, for revenues of nearly $14.9 billion, up 7 .4% (including +7.5%…
Inventiva receives a €4 million milestone payment from AbbVie following the launch of the Phase IIb study with cedirogant – 01/31/2022 at 22:00
Daix (France), Long Island City (New York), United States, January 31, 2022 – Inventiva SA (“Inventiva” or the “Company”) (Euronext Paris and Nasdaq: IVA), a biopharmaceutical company specializing in the…
Inventiva receives a €4 million milestone payment from AbbVie following the launch of the Phase IIb study with cedirogant – 01/31/2022 at 22:00
Daix (France), Long Island City (New York), United States January 31, 2022 – Inventiva SA (“Inventiva” or the “Company”) (Euronext Paris and Nasdaq: IVA), a biopharmaceutical company specializing in the…